{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:46:54Z","timestamp":1793429214353,"version":"4.5.0"},"reference-count":19,"publisher":"American Association for Cancer Research (AACR)","issue":"7","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chromosomal rearrangements account for all erythroblast transformation\u2013specific (ETS) family member gene fusions that have been reported in prostate cancer and have clinical, diagnostic, and prognostic implications. Androgen-regulated genes account for the majority of the 5\u2032 genomic regulatory promoter elements fused with ETS genes. TMPRSS2-ERG, TMPRSS2-ETV1, and SLC45A3-ERG rearrangements account for roughly 90% of ETS fusion prostate cancer. ELK4, another ETS family member, is androgen regulated, involved in promoting cell growth, and highly expressed in a subset of prostate cancer, yet the mechanism of ELK4 overexpression is unknown. In this study, we identified a novel ETS family fusion transcript, SLC45A3-ELK4, and found it to be expressed in both benign prostate tissue and prostate cancer. We found high levels of SLC45A3-ELK4 mRNA restricted to a subset of prostate cancer samples. SLC45A3-ELK4 transcript can be detected at high levels in urine samples from men at risk for prostate cancer. Characterization of the fusion mRNA revealed a major variant in which SLC45A3 exon 1 is fused to ELK4 exon 2. Based on quantitative PCR analyses of DNA, unlike other ETS fusions described in prostate cancer, the expression of SLC45A3-ELK4 mRNA is not exclusive to cases harboring a chromosomal rearrangement. Treatment of LNCaP cancer cells with a synthetic androgen (R1881) revealed that SLC45A3-ELK4, and not endogenous ELK4, mRNA expression is androgen regulated. Altogether, our findings show that SLC45A3-ELK4 mRNA expression is heterogeneous, highly induced in a subset of prostate cancers, androgen regulated, and most commonly occurs through a mechanism other than chromosomal rearrangement (e.g., trans-splicing). [Cancer Res 2009;69(7):2734\u20138]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-4926","type":"journal-article","created":{"date-parts":[[2009,3,17]],"date-time":"2009-03-17T22:13:29Z","timestamp":1237328009000},"page":"2734-2738","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":191,"title":["SLC45A3-ELK4 Is a Novel and Frequent Erythroblast Transformation\u2013Specific Fusion Transcript in Prostate Cancer"],"prefix":"10.1158","volume":"69","author":[{"given":"David S.","family":"Rickman","sequence":"first","affiliation":[{"name":"1Pathology and Laboratory Medicine and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"Pflueger","sequence":"additional","affiliation":[{"name":"1Pathology and Laboratory Medicine and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Moss","sequence":"additional","affiliation":[{"name":"1Pathology and Laboratory Medicine and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa E.","family":"VanDoren","sequence":"additional","affiliation":[{"name":"1Pathology and Laboratory Medicine and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen X.","family":"Chen","sequence":"additional","affiliation":[{"name":"1Pathology and Laboratory Medicine and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"de la Taille","sequence":"additional","affiliation":[{"name":"4Department of Urology, CHU Mondor and"},{"name":"5Institut National de la Sante et de la Recherche Medicale, Unite\u0301 841, Cre\u0301teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Kuefer","sequence":"additional","affiliation":[{"name":"6Department of Urology, University Hospital Ulm, Ulm, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh K.","family":"Tewari","sequence":"additional","affiliation":[{"name":"2Urology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita R.","family":"Setlur","sequence":"additional","affiliation":[{"name":"7Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Demichelis","sequence":"additional","affiliation":[{"name":"1Pathology and Laboratory Medicine and Departments of"},{"name":"3Institute for Computational Biomedicine, Weill Cornell Medical College, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Rubin","sequence":"additional","affiliation":[{"name":"1Pathology and Laboratory Medicine and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,4,1]]},"reference":[{"key":"2022061701490065300_B1","doi-asserted-by":"crossref","unstructured":"Mosquera JM, Perner S, Demichelis F, et al. Morphological features of TMPRSS2-ERG gene fusion prostate cancer. J Pathol\u20082007; 212: 91\u2013101.","DOI":"10.1002\/path.2154"},{"key":"2022061701490065300_B2","doi-asserted-by":"crossref","unstructured":"Attard G, Clark J, Ambroisine L, et al. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene\u20082008; 27: 253\u201363.","DOI":"10.1038\/sj.onc.1210640"},{"key":"2022061701490065300_B3","doi-asserted-by":"crossref","unstructured":"Demichelis F, Fall K, Perner S, et al. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene\u20082007; 26: 4596\u20139.","DOI":"10.1038\/sj.onc.1210237"},{"key":"2022061701490065300_B4","doi-asserted-by":"crossref","unstructured":"Setlur SR, Mertz KD, Hoshida Y, et al. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst\u20082008; 100: 815\u201325.","DOI":"10.1093\/jnci\/djn150"},{"key":"2022061701490065300_B5","doi-asserted-by":"crossref","unstructured":"Tomlins SA, Rhodes DR, Yu J, et al. The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell\u20082008; 13: 519\u201328.","DOI":"10.1016\/j.ccr.2008.04.016"},{"key":"2022061701490065300_B6","doi-asserted-by":"crossref","unstructured":"Tomlins SA, Laxman B, Dhanasekaran SM, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature\u20082007; 448: 595\u20139.","DOI":"10.1038\/nature06024"},{"key":"2022061701490065300_B7","doi-asserted-by":"crossref","unstructured":"Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science\u20082005; 310: 644\u20138.","DOI":"10.1126\/science.1117679"},{"key":"2022061701490065300_B8","doi-asserted-by":"crossref","unstructured":"Helgeson BE, Tomlins SA, Shah N, et al. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Cancer Res\u20082008; 68: 73\u201380.","DOI":"10.1158\/0008-5472.CAN-07-5352"},{"key":"2022061701490065300_B9","doi-asserted-by":"crossref","unstructured":"Han B, Mehra R, Dhanasekaran SM, et al. A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-4 fusion protein in prostate cancer. Cancer Res\u20082008; 68: 7629\u201337.","DOI":"10.1158\/0008-5472.CAN-08-2014"},{"key":"2022061701490065300_B10","doi-asserted-by":"crossref","unstructured":"Makkonen H, Jaaskelainen T, Pitkanen-Arsiola T, et al. Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells. Oncogene\u20082008; 27: 4865\u201376.","DOI":"10.1038\/onc.2008.125"},{"key":"2022061701490065300_B11","doi-asserted-by":"crossref","unstructured":"McCarroll SA, Kuruvilla FG, Korn JM, et al. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet\u20082008; 40: 1166\u201374.","DOI":"10.1038\/ng.238"},{"key":"2022061701490065300_B12","doi-asserted-by":"crossref","unstructured":"Wolf M, Mousses S, Hautaniemi S, et al. High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. Neoplasia\u20082004; 6: 240\u20137.","DOI":"10.1593\/neo.03439"},{"key":"2022061701490065300_B13","doi-asserted-by":"crossref","unstructured":"Perner S, Demichelis F, Beroukhim R, et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res\u20082006; 66: 8337\u201341.","DOI":"10.1158\/0008-5472.CAN-06-1482"},{"key":"2022061701490065300_B14","doi-asserted-by":"crossref","unstructured":"Takahara T, Tasic B, Maniatis T, Akanuma H, Yanagisawa S. Delay in synthesis of the 3\u2032 splice site promotes trans-splicing of the preceding 5\u2032 splice site. Mol Cell\u20082005; 18: 245\u201351.","DOI":"10.1016\/j.molcel.2005.03.018"},{"key":"2022061701490065300_B15","doi-asserted-by":"crossref","unstructured":"Pradet-Balade B, Medema JP, Lopez-Fraga M, et al. An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein. EMBO J\u20082002; 21: 5711\u201320.","DOI":"10.1093\/emboj\/cdf565"},{"key":"2022061701490065300_B16","doi-asserted-by":"crossref","unstructured":"Akiva P, Toporik A, Edelheit S, et al. Transcription-mediated gene fusion in the human genome. Genome Res\u20082006; 16: 30\u20136.","DOI":"10.1101\/gr.4137606"},{"key":"2022061701490065300_B17","doi-asserted-by":"crossref","unstructured":"Hessels D, Smit FP, Verhaegh GW, Witjes JA, Cornel EB, Schalken JA. Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer. Clin Cancer Res\u20082007; 13: 5103\u20138.","DOI":"10.1158\/1078-0432.CCR-07-0700"},{"key":"2022061701490065300_B18","doi-asserted-by":"crossref","unstructured":"Laxman B, Morris DS, Yu J, et al. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res\u20082008; 68: 645\u20139.","DOI":"10.1158\/0008-5472.CAN-07-3224"},{"key":"2022061701490065300_B19","doi-asserted-by":"crossref","unstructured":"Maher CA, Kumar-Sinha C, Cao X, et al. Transcriptome sequencing to detect gene fusions in cancer. Nature Epub 2009 Jan 11.","DOI":"10.1038\/nature07638"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/7\/2734\/2623922\/2734.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/7\/2734\/2623922\/2734.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T05:21:35Z","timestamp":1655443295000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/7\/2734\/553335\/SLC45A3-ELK4-Is-a-Novel-and-Frequent-Erythroblast"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,1]]},"references-count":19,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2009,4,1]]},"published-print":{"date-parts":[[2009,4,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-4926","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22379720.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22379720","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22379717.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22379723","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499337.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22379717","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22379723.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499337","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,1]]}}}